PRF Technologies (PRFX) Non-Current Assets (2019 - 2025)
PRF Technologies' (PRFX) quarterly Non-Current Assets came in at $7.6 million in Q4 2025, up 69418.18% YoY from N/an in Q4 2024, and up 5.43% on a QoQ basis from $7.3 million in Q2 2025.
PRF Technologies (PRFX) Non-Current Assets (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 7 years of Non-Current Assets data on file, last reported at $7.6 million in Q4 2025.
- Quarterly Non-Current Assets rose 69418.18% year-over-year to $7.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.8 million (up 70545.45% YoY) and the FY2025 annual result came in at $7.6 million, up 69418.18% from the prior year.
- Non-Current Assets grew to $7.6 million in Q4 2025, from $7.3 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $7.6 million in Q4 2025 to a low of $11000.0 in Q4 2024.
- A 5-year average of $924352.9 and a median of $44000.0 in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2021 — Non-Current Assets sank 91.24% — and 2025, when it surged 69418.18%.
- Tracing PRFX's Non-Current Assets over 5 years: stood at $53000.0 in 2021, then retreated by 16.98% to $44000.0 in 2022, then tumbled by 59.09% to $18000.0 in 2023, then slumped by 38.89% to $11000.0 in 2024, then surged by 69418.18% to $7.6 million in 2025.
- The last three Non-Current Assets figures came in at $7.6 million (Q4 2025), $7.3 million (Q2 2025), and $11000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | 7.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.65 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Dec 31, 2024 | 11,000.00 |
| Jun 30, 2024 | 115,000.00 |
| Mar 31, 2024 | 124,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | 146,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 44,000.00 |
| Sep 30, 2022 | 44,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Mar 31, 2022 | 51,000.00 |
| Dec 31, 2021 | 53,000.00 |
| Sep 30, 2021 | 28,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | 22,000.00 |
| Dec 31, 2020 | 10,000.00 |
| Jun 30, 2020 | 274,000.00 |
| Dec 31, 2019 | 192,000.00 |